Breaking News Instant updates and real-time market news.

DIS

Disney

$111.87

-0.41 (-0.37%)

, CBS

CBS

$57.68

-1.525 (-2.58%)

13:29
01/04/18
01/04
13:29
01/04/18
13:29

NFL ratings decline at steeper pace from last year, WSJ reports

The average television audience for a National Football League game this season was 14.9M, a 9.7% decline from last year's 16.5M viewers per game, the Wall Street Journal reports, citing Nielsen. The 9.7% dip marks a steeper decline than the 8% viewership erosion last year, the report notes. Various TV executives have said that, while viewers leaving due to player protests might be playing a role in lower ratings, overexposure of NFL programming is the primary cause of the decline, the report notes. Other executives have noted that the league, which has long been viewed as invincible, is simply being affected by changes in the broader TV business as more viewers shift from traditional cable TV packages to digital services, the report notes. Companies that distribute NFL content include Disney (DIS), CBS (CBS), 21st Century Fox (FOXA), Comcast (CMCSA), Twitter (TWTR), and Verizon (VZ). Reference Link

DIS

Disney

$111.87

-0.41 (-0.37%)

CBS

CBS

$57.68

-1.525 (-2.58%)

FOX

21st Century Fox

$35.93

0.57 (1.61%)

FOXA

21st Century Fox

$36.54

0.68 (1.90%)

CMCSA

Comcast

$40.41

-0.66 (-1.61%)

CMCSK

Comcast

$58.00

(0.00%)

TWTR

Twitter

$23.82

-0.631 (-2.58%)

VZ

Verizon

$52.75

0.32 (0.61%)

  • 08

    Jan

  • 09

    Jan

  • 11

    Jan

  • 23

    Jan

  • 07

    Feb

  • 15

    Feb

DIS Disney
$111.87

-0.41 (-0.37%)

01/04/18
WELS
01/04/18
NO CHANGE
WELS
Media sector upgraded to Over Weight from Market Weight at Wells Fargo
Wells Fargo analyst Marci Ryvicker upgraded the Media sector to Over Weight from Market Weight citing her positive views on shares of 21st Century Fox (FOXA), Disney (DIS), CBS (CBS) and AMC Networks (AMCX). Fox is the analyst's top near-term pick in the space, with Disney "a close second."
01/03/18
RBCM
01/03/18
NO CHANGE
Target $43
RBCM
Outperform
21st Century Fox price target raised to $43 from $34 at RBC Capital
RBC Capital analyst Steven Cahall raised his price target on 21st Century Fox (FOXA) to $43 and kept his Outperform rating in the wake of the asset sale to Disney (DIS). Cahall says the valuation on the SpinCo implies a 20% free cash flow yield relative to 7% at its peer CBS (CBS), and expects this discount to be corrected with an upside in the stock once the deal is fully priced in. The analyst also sees the immediate outlook for the company's revenue growth as "solid".
01/03/18
RSBL
01/03/18
UPGRADE
Target $130
RSBL
Buy
Disney upgraded to Buy from Neutral at Rosenblatt
Rosenblatt analyst Alan Gould upgraded Disney to Buy from Neutral and raised his price target on the shares to $130 from $115.
01/03/18
RBCM
01/03/18
NO CHANGE
Target $135
RBCM
Top Pick
Disney price target raised to $135 from $125 at RBC Capital
RBC Capital analyst Steven Cahall raised his price target on Disney (DIS) to $135 and kept his Top Pick rating. Cahall says the company deserves to trade at a premium to the market based on its insulation to ecosystem challenges, anticipated "major" tax reform benefits, and evolving content with the 21st Century Fox (FOXA) deal. The analyst adds that the company's Consumer Products, Studio, and Parks segments will continue to provide years of steady cash flow and growth.
CBS CBS
$57.68

-1.525 (-2.58%)

01/04/18
WELS
01/04/18
NO CHANGE
Target $70
WELS
Outperform
CBS price target lowered to $70 form $75 at Wells Fargo
Wells Fargo analyst Marci Ryvicker lowered her price target for CBS to $70 from $75 to incorporate tax reform. The analyst reiterates an Outperform rating on the shares.
01/03/18
RBCM
01/03/18
NO CHANGE
Target $40
RBCM
Outperform
Lionsgate price target raised to $40 from $36 at RBC Capital
RBC Capital analyst Steven Cahall raised his price target on Lions Gate Entertainment (LGF.B) to $40, calling it his "Top smidcap" for 2018. Cahall says that the company is a "content pureplay", which makes it defensive to changes in the ecosystem, adding that it is also the "most likely acquisition target in the space." The analyst points to reduction in earnings volatility through Starz, which he believes has an upside to its current distribution of 25M subscriptions. While there have been a number of potential suitors that want to own content, Cahall believes CBS (CBS) is the most "logical" one.
FOX 21st Century Fox
$35.93

0.57 (1.61%)

12/13/17
BTIG
12/13/17
NO CHANGE
BTIG
Disney, Fox deal may be a near-term positive for Netflix, BTIG says
Commenting on Disney's (DIS) deal with Fox (FOX; FOXA) and its potential implications, BTIG's Richard Greenfield notes that the knee jerk reaction he hears across the investment world is the former is buying the later to build their "Netflix killer." Greenfield "strongly disagrees" with this viewpoint, saying that if Disney wanted to build a Netflix competitor it should be eliminating its stock buyback and aggressively investing in content that has no legacy media strings attached. Further, the Disney/Fox transaction is likely a near-to-intermediate term positive for Netflix, he argues, adding that both companies will be tied up in a 12 month or more regulatory review process with thousands of executives in limbo pending the closing of the transaction.
12/13/17
FBNS
12/13/17
NO CHANGE
FBNS
FBN says Fox could be worth over $42 per share with Disney deal
With multiple media report indicating that Disney (DIS) is close to finalizing a deal to buy most of 21st Century Fox's (FOX) assets and operations, FBN Securities analyst Robert Routh is estimating that Fox shares could have a "real value" of $42.46 based on what has been reported on the likely deal. This estimate is before considering taxes and taking into account that Disney shares will likely rise after a deal is confirmed, said Routh, who does not officially cover either Disney or Fox.
12/11/17
BTIG
12/11/17
NO CHANGE
BTIG
BTIG says Comcast could pay 'significantly' more for Fox assets than Disney
BTIG analyst Richard Greenfield said earlier in a note to investors that he believes Comcast (CMCSA) could pay "significantly more" for the assets that Fox (FOXA) is reportedly looking to sell than could Disney (DIS). He also believes Comcast could have a better chance of securing regulatory approval for a deal if they are willing to spin off all of the regional sports networks that a combined entity would own.
12/18/17
UBSW
12/18/17
NO CHANGE
Target $122
UBSW
Buy
Disney deal for Fox fits both strategically and financially, says UBS
UBS analyst John Hodulik said Disney's (DIS) deal for Fox (FOXA) strengthens its asset base amid the evolving media landscape and fits well both strategically and financially. He believes the deal enhances Disney's growth trajectory and will be accretive to 2020 free cash flow while helping it widen its appeal and target audience. Hodulik reiterated his Buy rating and $122 price target on Disney shares.
FOXA 21st Century Fox
$36.54

0.68 (1.90%)

01/02/18
LOOP
01/02/18
NO CHANGE
Target $241
LOOP
Buy
Netflix is 'Best Idea for 2018', says Loop Capital
Loop Capital analyst David Miller calls Netflix (NFLX) his Best Idea for 2018, keeping a Buy rating on the stock while nudging his price target to $241 from $237. Miller says the company will follow up on last year's "notable" subscriber growth with "true operating leverage" this year. The analyst also contends that Disney's (DIS) acquisition of 21st Century Fox (FOXA) entertainment assets does not necessarily make it a winner in the Over-The-Top space, since it may not launch a competitive service until mid-2019.
CMCSA Comcast
$40.41

-0.66 (-1.61%)

12/07/17
JEFF
12/07/17
NO CHANGE
JEFF
Jefferies sees Disney, not Comcast, as more likely Fox suitor
Amid press reports that suggest Comcast (CMCSA) continues to pursue 21st Century Fox (FOXA) along with Disney (DIS), Jefferies analyst John Janedis says he sees Disney as the more likely suitor given the regulatory concerns with a Comcast deal. The analyst believes Comcast would need to offer a premium to Disney for Fox to compensate for more regulatory risk. However, assuming Comcast has interest in the same assets as Disney, and using the same $66B value for Fox's assets, the analyst estimates the deal would be high-single-digit dilutive to Comcast earnings, versus neutral to Disney due to relative tax rates.
12/13/17
RILY
12/13/17
DOWNGRADE
Target $18
RILY
Neutral
TiVo downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR analyst Eric Wold downgraded TiVo (TIVO) to Neutral and lowered his price target for the shares to $18 from $24. The analyst has heightened concerns around the company's dispute with Comcast (CMCSA). The cable giant has worked around the ITC ruling, which opens the door to potentially working to avoid an ongoing license, Wold tells investors in a research note.
01/04/18
JPMS
01/04/18
NO CHANGE
Target $34
JPMS
Overweight
TiVo leveraged buyout makes sense with Comcast contract, says JPMorgan
JPMorgan analyst Sterling Auty believes a leveraged buyout of TiVo (TIVO) would make sense if the company can successfully reach a new contract deal with Comcast (CMCSA). The Street reported on December 29 that TiVo has received multiple expressions of interest from private equity buyers at an acquisition price slightly north of $20. A successful deal above $20 would need a positive outcome with Comcast settling on a new contract, Auty tells investors in a research note. At the different levels of leverage, the analyst feels a financial sponsor can offer as much as a mid-$20 per share price for TiVo. Even without a transaction, the analyst still stills believe TiVo has the potential to unlock shareholder value with its 4.9% dividend yield, cost synergies, and cash flow outlook. Auty has an Overweight rating on the stock with a $34 price target.
CMCSK Comcast
$58.00

(0.00%)

11/22/17
PIPR
11/22/17
NO CHANGE
Target $25
PIPR
Overweight
TiVo ITC win raises odds of Comcast renewal, says Piper Jaffray
Piper Jaffray analyst Michael Olson said the International Trade Commission ruling in favor of TiVo (TIVO) increases the likelihood that a renewal deal with Comcast (CMCSA) will be reached, but he does not have it built into his estimates until early 2018. He maintains an Overweight rating and $25 price target on TiVo shares, which are up nearly 13% to $19.90 in pre-market trading.
11/13/17
PIPR
11/13/17
NO CHANGE
PIPR
Overweight
TiVo CEO selection removes one uncertainty, says Piper Jaffray
Piper Jaffray analyst Michael Olson noted that TiVo's (TIVO) newly-named CEO Enrique Rodriguez has a "strong industry background" including experience launching and improving various entertainment platforms. Olson added that the CEO selection removes one uncertainty, but the status of a renewal at Comcast (CMCSA) remains investors' primary focus. He keeps an Overweight rating on TiVo shares.
11/10/17
COWN
11/10/17
NO CHANGE
Target $30
COWN
Outperform
Court win versus Comcast could lift TiVo shares $6, says Cowen
Cowen analyst Robert Stone noted the FTC has extended its target date for completion of the TiVo (TIVO) and Comcast (CMCSA) investigation to November 16. The analyst believes TiVo will prevail and he believes a win could add $6 to its current valuation. Stone also believes Tivo remains significantly undervalued and he reiterated his Outperform rating and $30 price target on TiVo shares.
TWTR Twitter
$23.82

-0.631 (-2.58%)

12/18/17
12/18/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Twitter (TWTR) initiated with a Buy at Summit Redstone. 2. Insteel (IIIN) initiated with a Buy at Sidoti. 3. Tiffany (TIF) initiated with a Neutral at JPMorgan. 4. Delphi Technologies (DLPH) initiated with a Buy at Jefferies. 5. Domino's Pizza (DPZ) initiated with a Buy at Deutsche Bank, while Papa John's and Wingstop (WING) were initiated with a Hold. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/20/17
ARGS
12/20/17
NO CHANGE
Target $30
ARGS
Buy
Twitter price target raised to $30 from $25 at Argus
Argus analyst Jim Kelleher raised his price target price on Twitter to $30 from $25, stating that he believes the shares have further to go despite the stock's over 25% run-up since his upgrade in November. Twitter is restoring growth while seeking to improve, but not stifle, the user experience and Kelleher thinks its continued work on refining and clarifying its policy on toxic content can help restore the company's early mission of serving as a platform for public self-expression, he tells investors. Kelleher keeps a Buy rating on Twitter shares.
12/18/17
12/18/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Overweight from Neutral at JPMorgan with analyst Doug Anmuth saying both the company's investment story and financial results will strengthen in 2018 as Twitter builds on its "differentiated value proposition" for users and returns to revenue growth. 2. Akamai (AKAM) upgraded to Outperform from Neutral at Credit Suisse with analyst Brad Zelnick citing the 13D filing by activist investor Elliott Management. 3. Costco (COST) upgraded to Outperform from Market Perform at BMO Capital with analyst Kelly Bania saying the acceleration in the company's online business is at an early stage, which should support its outlook for strong comps and higher valuation. 4. General Mills (GIS) upgraded to Outperform from Market Perform at Wells Fargo with analyst John Baumgartner saying U.S. retail takeaway is improving faster than he expected, which suggests potential upside to the company's guidance during fiscal 2018. 5. Discover (DFS) and Synchrony (SYF) were upgraded to Buy from Neutral at BofA Merrill Lynch. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/18/17
SMTR
12/18/17
INITIATION
Target $26
SMTR
Buy
Twitter initiated with a Buy at Summit Redstone
Summit Redstone analyst Jonathan Kees started Twitter with a Buy rating and $26 price target. The analyst sees an opportunity in the shares for 2018 as easier comparisons could lead to revenue growth. JPMorgan this morning upgraded Twitter to Overweight.
VZ Verizon
$52.75

0.32 (0.61%)

12/12/17
NOMU
12/12/17
UPGRADE
Target $61
NOMU
Buy
Verizon upgraded to Buy from Neutral at Nomura Instinet
Nomura Instinet analyst Jeffrey Kvaal upgraded Verizon Communications to Buy and raised his price target for the shares to $61 from $47. The stock closed yesterday up 75c to $51.84. Better visibility into subscriber growth, rising average revenue per user and cost control will drive earnings growth in 2018, Kvaal tells investors in a research note. Further, he believes tax reform should also boost the company's earnings. The analyst thinks signs of easing competition may also spur multiple expansion.
12/12/17
12/12/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Verizon (VZ) upgraded to Buy from Neutral at Nomura Instinet by analyst Jeffrey Kvaal, who said that better visibility into subscriber growth, rising average revenue per user and cost control will drive earnings growth in 2018. Further, he believes tax reform should also boost the company's earnings. The analyst thinks signs of easing competition may also spur multiple expansion. 2. Northrop Grumman (NOC) upgraded to Overweight from Neutral at JPMorgan by analyst Seth Seifman, who said that more profitable F-35 growth will accelerate in 2018 while management's initial take on the Orbital ATK (OA) deal, including synergies, will prove conservative. He called Northrop his top defense prime pick. 3. Activision Blizzard (ATVI) upgraded to Buy from Neutral at Goldman Sachs by analyst Christopher Merwin, who recommends owning this discounted "high-quality" asset ahead of accelerating earnings growth over the next 2-3 years. Merwin raised Activision's 2019 and 2020 estimates to reflect a robust pipeline of games including Diablo, Overwatch 2, and a Blizzard mobile title, which he does not believe Street estimates fully reflect. 4. Abbott (ABT) upgraded to Outperform from Market Perform at BMO Capital by analyst Joanne Wuensch, who said she is placing the stock on her "Top Picks" list, noting that 2018 will be the "year of execution" with several product launches ahead and acquisitions of Alere and St. June in the past. 5. HCA Healthcare (HCA), Tenet (THC) and Universal Health (UHS) upgraded to Buy from Neutral at Citi by analyst Ralph Giacobbe, who cited a more constructive view on the hospital space. The analyst sees a better volume backdrop in 2018 and low expectations for the sector. He believes hospital stocks offer an attractive upside scenario. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/14/17
HSBC
12/14/17
DOWNGRADE
Target $52
HSBC
Hold
Verizon downgraded to Hold on valuation at HSBC
HSBC analyst Sunil Rajgopal downgraded Verizon to Hold from Buy saying the recent rally limits upside and maintained a $52 price target.
12/14/17
12/14/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Verizon (VZ) downgraded to Hold on valuation at HSBC with analyst Sunil Rajgopal saying the recent rally limits upside. 2. Blue Buffalo Pet Products (BUFF) downgraded to Hold from Buy at Deutsche Bank with analyst Faiza Alwy citing valuation concerns as the stock is up 35% over the last six months. 3. Nielsen (NLSN) downgraded to Underweight from Equal Weight at Barclays with analyst Manav Patnaik saying he sees challenging end markets for the company as well as credibility concerns following a year of "poor" execution. 4. Valeant (VRX) downgraded to Underweight from Neutral at JPMorgan with analyst Chris Schott saying he sees better opportunities in the sector following the recent rally in the shares. 5. Pier 1 Imports (PIR) downgraded to Sell from Hold at Gordon Haskett with analyst Chuck Grom citing the third quarter miss and lowered guidance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CREE

Cree

$50.17

-0.11 (-0.22%)

, ZTCOY

ZTE Corp.

$0.00

(0.00%)

08:46
08/15/18
08/15
08:46
08/15/18
08:46
Recommendations
Cree, ZTE Corp. analyst commentary  »

Cree organic growth above…

CREE

Cree

$50.17

-0.11 (-0.22%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

DRYS

DryShips

$4.60

-0.05 (-1.08%)

08:46
08/15/18
08/15
08:46
08/15/18
08:46
Hot Stocks
DryShips announces sale of Panamax drybulk carrier »

DryShips announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:46
08/15/18
08/15
08:46
08/15/18
08:46
Conference/Events
The Washington Journal holds a discussion on NAFTA renegotiations & trade policy »

Public Citizen Global…

08:45
08/15/18
08/15
08:45
08/15/18
08:45
General news
U.S. retail sales rose 0.5% in July, with the ex-auto component up 0.6% »

U.S. retail sales rose…

HMNY

Helios and Matheson

$0.05

0.0001 (0.20%)

, ASHR

X-trackers Harvest CSI 300

$24.87

(0.00%)

08:45
08/15/18
08/15
08:45
08/15/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

HMNY

Helios and Matheson

$0.05

0.0001 (0.20%)

ASHR

X-trackers Harvest CSI 300

$24.87

(0.00%)

JNK

SPDR Barclays High Yield Bond

$35.86

0.065 (0.18%)

IRBT

iRobot

$87.83

1.72 (2.00%)

ENB

Enbridge

$35.51

0.3108 (0.88%)

WLL

Whiting Petroleum

$48.18

1.73 (3.72%)

HEAR

Turtle Beach

$26.80

-1.15 (-4.11%)

AMJ

American Medical Laboratories Inc

$29.11

0.2 (0.69%)

UCO

Universal Compression

$29.37

-0.06 (-0.20%)

GOGO

Gogo

$4.42

0.05 (1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 04

    Sep

  • 05

    Sep

  • 06

    Sep

  • 13

    Sep

08:45
08/15/18
08/15
08:45
08/15/18
08:45
General news
FX Action: The dollar »

FX Action: The dollar…

08:45
08/15/18
08/15
08:45
08/15/18
08:45
General news
U.S. Empire State manufacturing index bounced 3 points to 25.6 in August »

U.S. Empire State…

08:42
08/15/18
08/15
08:42
08/15/18
08:42
Conference/Events
RBC Capital to hold a conference »

Consumer Investor Day…

08:41
08/15/18
08/15
08:41
08/15/18
08:41
Conference/Events
Stephens to hold a field trip »

Building Products…

BKH

Black Hills

$60.23

0.235 (0.39%)

, GGG

Graco

$46.02

0.025 (0.05%)

08:40
08/15/18
08/15
08:40
08/15/18
08:40
Conference/Events
CFA Society of Minnesota to hold a conference »

7th Annual Investor…

BKH

Black Hills

$60.23

0.235 (0.39%)

GGG

Graco

$46.02

0.025 (0.05%)

CLFD

Clearfield

$13.05

0.35 (2.76%)

CYBE

Cyberoptics

$19.25

0.05 (0.26%)

CHRW

C.H. Robinson

$93.98

0.02 (0.02%)

DAKT

Daktronics

$8.43

0.02 (0.24%)

CBZ

CBIZ

$22.93

0.275 (1.21%)

DGII

Digi International

$12.95

-0.025 (-0.19%)

PII

Polaris Industries

$107.72

0.42 (0.39%)

ASV

ASV Holdings

$6.28

-0.27 (-4.12%)

ALE

Allete

$77.99

0.97 (1.26%)

DOC

Physicians Realty Trust

$16.83

0.22 (1.32%)

APOG

Apogee Enterprises

$49.74

0.55 (1.12%)

MOS

Mosaic

$30.63

0.25 (0.82%)

DCI

Donaldson

$47.69

0.88 (1.88%)

SRDX

Surmodics

$73.05

2.1 (2.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 15

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 26

    Aug

  • 06

    Sep

  • 06

    Sep

  • 29

    Oct

  • 06

    Nov

SHLX

Shell Midstream

$22.73

0.35 (1.56%)

08:39
08/15/18
08/15
08:39
08/15/18
08:39
Hot Stocks
Shell Midstream joint venture Zydeco announces binding open season »

Zydeco, jointly owned by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMG

KMG Chemicals

$66.78

0.1 (0.15%)

08:37
08/15/18
08/15
08:37
08/15/18
08:37
Hot Stocks
Breaking Hot Stocks news story on KMG Chemicals »

KMG Chemicals trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$129.47

-0.67 (-0.51%)

08:36
08/15/18
08/15
08:36
08/15/18
08:36
Recommendations
Lululemon analyst commentary  »

Lululemon price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

IDXG

Interpace Diagnostics

$1.03

-0.01 (-0.96%)

08:36
08/15/18
08/15
08:36
08/15/18
08:36
Hot Stocks
Interpace Diagnostics acquires assets of Rosetta Genomics out of bankruptcy »

Interpace Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$193.08

-1.03 (-0.53%)

08:34
08/15/18
08/15
08:34
08/15/18
08:34
Recommendations
Home Depot analyst commentary  »

Stifel sees 'no…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$1.03

(0.00%)

08:33
08/15/18
08/15
08:33
08/15/18
08:33
Hot Stocks
CEL-SCI says IDMC recommends continuation of Phase 3 head and neck cancer study »

CEL-SCI announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:33
08/15/18
08/15
08:33
08/15/18
08:33
General news
Empire State Mfg Survey General Business Conditions Index data reported »

August Empire State Mfg…

CE

Celanese

$116.73

0.7 (0.60%)

08:32
08/15/18
08/15
08:32
08/15/18
08:32
Hot Stocks
Celanese granted four new patents for Sunett sweetner »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

CYTX

Cytori Therapeutics

$0.40

0.015 (3.95%)

08:32
08/15/18
08/15
08:32
08/15/18
08:32
Downgrade
Cytori Therapeutics rating change  »

Cytori Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMG

KMG Chemicals

$66.78

0.1 (0.15%)

, CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

08:31
08/15/18
08/15
08:31
08/15/18
08:31
Conference/Events
Cabot Microelectronics to hold a conference call »

Conference call to…

KMG

KMG Chemicals

$66.78

0.1 (0.15%)

CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 11

    Sep

TPR

Tapestry

$53.12

5.7 (12.02%)

08:31
08/15/18
08/15
08:31
08/15/18
08:31
Recommendations
Tapestry analyst commentary  »

Tapestry price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

, KMG

KMG Chemicals

$66.78

0.1 (0.15%)

08:30
08/15/18
08/15
08:30
08/15/18
08:30
Hot Stocks
Cabot Microelectronics to acquire KMG Chemicals for $1.6B »

Cabot Microelectronics…

CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

KMG

KMG Chemicals

$66.78

0.1 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 11

    Sep

ASRT

Assertio Therapeutics

$7.31

0.135 (1.88%)

, JNP

Juniper Pharmaceuticals

$11.50

(0.00%)

08:30
08/15/18
08/15
08:30
08/15/18
08:30
Options
One new option listing and three option delistings on August 15th »

New option listings for…

ASRT

Assertio Therapeutics

$7.31

0.135 (1.88%)

JNP

Juniper Pharmaceuticals

$11.50

(0.00%)

XPLR

Xplore Technologies

$5.99

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STIM

Neuronetics

$32.28

-1.72 (-5.06%)

08:28
08/15/18
08/15
08:28
08/15/18
08:28
Recommendations
Neuronetics analyst commentary  »

Neuronetics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNC

Tennant

$76.60

-0.85 (-1.10%)

08:28
08/15/18
08/15
08:28
08/15/18
08:28
Conference/Events
Tennant management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.